LLY

1,040.97

+2.7%↑

JNJ

231.49

+0.92%↑

ABBV

214.52

+0.83%↑

UNH

382.43

-0.24%↓

AZN

189.76

+1.28%↑

LLY

1,040.97

+2.7%↑

JNJ

231.49

+0.92%↑

ABBV

214.52

+0.83%↑

UNH

382.43

-0.24%↓

AZN

189.76

+1.28%↑

LLY

1,040.97

+2.7%↑

JNJ

231.49

+0.92%↑

ABBV

214.52

+0.83%↑

UNH

382.43

-0.24%↓

AZN

189.76

+1.28%↑

LLY

1,040.97

+2.7%↑

JNJ

231.49

+0.92%↑

ABBV

214.52

+0.83%↑

UNH

382.43

-0.24%↓

AZN

189.76

+1.28%↑

LLY

1,040.97

+2.7%↑

JNJ

231.49

+0.92%↑

ABBV

214.52

+0.83%↑

UNH

382.43

-0.24%↓

AZN

189.76

+1.28%↑

Search

STERIS PLC

Fechado

SetorSaúde

218.7 1.65

Visão Geral

Variação de preço das ações

24h

Atual

Mín

211.02

Máximo

219.62

Indicadores-chave

By Trading Economics

Rendimento

26M

220M

Vendas

92M

1.6B

P/E

Médio do Setor

26.748

49.701

EPS

2.83

Rendimento de Dividendos

1.14

Margem de lucro

13.869

Funcionários

17,787

EBITDA

48M

317M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+31.73% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

1.14%

2.39%

Próximos Ganhos

5 de ago. de 2026

Próxima data de dividendos

26 de jun. de 2026

Próxima data de ex-dividendo

8 de jun. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-14M

21B

Abertura anterior

217.05

Fecho anterior

218.7

Sentimento de Notícias

By Acuity

28%

72%

60 / 345 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bearish Evidence

STERIS PLC Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

11 de mai. de 2026, 20:44 UTC

Ganhos

Steris: Board Approves New $1B Shr Repurchase Program >STE

11 de mai. de 2026, 20:30 UTC

Ganhos

Steris 4Q Cont Ops EPS $2.24 >STE

11 de mai. de 2026, 20:30 UTC

Ganhos

Steris 4Q Rev $1.6B >STE

11 de mai. de 2026, 20:30 UTC

Ganhos

Steris Sees FY Adj EPS $11.10-Adj EPS $11.30 >STE

11 de mai. de 2026, 20:30 UTC

Ganhos

Steris 4Q Adj EPS $2.83 >STE

4 de fev. de 2026, 21:30 UTC

Ganhos

Steris Sees FY Adj EPS $10.15-Adj EPS $10.30 >STE

4 de fev. de 2026, 21:30 UTC

Ganhos

Steris 3Q Rev $1.5B >STE

4 de fev. de 2026, 21:30 UTC

Ganhos

Steris 3Q Adj EPS $2.53 >STE

4 de fev. de 2026, 21:30 UTC

Ganhos

Steris 3Q Cont Ops EPS $1.96 >STE

5 de nov. de 2025, 21:30 UTC

Ganhos

Steris 2Q Cont Ops EPS $1.94 >STE

5 de nov. de 2025, 21:30 UTC

Ganhos

Steris 2Q Rev $1.5B >STE

5 de nov. de 2025, 21:30 UTC

Ganhos

Steris 2Q Adj EPS $2.47 >STE

6 de ago. de 2025, 20:30 UTC

Ganhos

Steris 1Q Adj EPS $2.34 >STE

6 de ago. de 2025, 20:30 UTC

Ganhos

Steris 1Q Rev $1.4B >STE

Comparação entre Pares

Variação de preço

STERIS PLC Previsão

Preço-alvo

By TipRanks

31.73% parte superior

Previsão para 12 meses

Média 284.5 USD  31.73%

Máximo 300 USD

Mínimo 269 USD

Com base em 3 analistas de Wall Street que oferecem metas de preço de 12 meses para STERIS PLC - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

3 ratings

2

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

225 / 226.35Suporte e Resistência

Curto Prazo

Bearish Evidence

Médio Prazo

Strong Bullish Evidence

Longo Prazo

Strong Bullish Evidence

Sentimento

By Acuity

60 / 345 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre STERIS PLC

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.
help-icon Live chat